The document provides an overview of the Investigational New Drug Application (IND) and New Drug Application (NDA) processes for bringing new drugs to market. It describes how an IND must be submitted to the FDA to test an experimental drug in humans, and outlines the types of INDs, content requirements, and review process. An NDA contains extensive clinical trial data and is required for FDA approval to commercially market a new drug. The lengthy and costly process from initial research to marketing approval averages 15 years and $900 million per new drug.
Abbreviated New Drug Application [ANDA]Sagar Savale
An Abbreviated New Drug Application (ANDA) contains data which when submitted to FDA's CDER, Office of Generic Drugs, provides for the review and ultimate approval of a generic drug product.
The NDA application is the vehicle through which drug sponsors, such as biotech and pharmaceutical companies, formally propose that the FDA approve a new pharmaceutical for sale and marketing
For better understanding of students. This will give you a detailed explanation of IND APPLICATION. Contact me through comment section if you need any assistance in understating this topic.
Abbreviated New Drug Application [ANDA]Sagar Savale
An Abbreviated New Drug Application (ANDA) contains data which when submitted to FDA's CDER, Office of Generic Drugs, provides for the review and ultimate approval of a generic drug product.
The NDA application is the vehicle through which drug sponsors, such as biotech and pharmaceutical companies, formally propose that the FDA approve a new pharmaceutical for sale and marketing
For better understanding of students. This will give you a detailed explanation of IND APPLICATION. Contact me through comment section if you need any assistance in understating this topic.
A brief presentation on the Code of Federal Regulations
Covers the following aspects -
- What is CFR?
-History of CFR
- CFR Title 21
- CFR in modern times.
- Research tools in CFR
- Whilst the realization of the CTD took many years, there is now a common format for the submission of Marketing Authorizations Applications across the three ICH regions - Europe, Japan and the USA.
- This should facilitate pharmaceutical companies to make simultaneous filings in the ICH regions as it will eliminate the extensive work previously required to convert, for example, a US dossier to an EU dossier and vice versa.
Clinical study on human subjects according to all guidelines to form a ideal protocol and requirement to conduct clinical trial with very efficient way mainly considering to India and ICH associated countries
A brief presentation on the Code of Federal Regulations
Covers the following aspects -
- What is CFR?
-History of CFR
- CFR Title 21
- CFR in modern times.
- Research tools in CFR
- Whilst the realization of the CTD took many years, there is now a common format for the submission of Marketing Authorizations Applications across the three ICH regions - Europe, Japan and the USA.
- This should facilitate pharmaceutical companies to make simultaneous filings in the ICH regions as it will eliminate the extensive work previously required to convert, for example, a US dossier to an EU dossier and vice versa.
Clinical study on human subjects according to all guidelines to form a ideal protocol and requirement to conduct clinical trial with very efficient way mainly considering to India and ICH associated countries
The presentation aims at a students focussed perspective of Abbreviated New Drug Application filing with premier regulatory body like USFDA, the eCTD is followed worldwide for drug submission aimed for gaining particular market approvals.When submitted with FDA it is evaluated by CDER. eCTD is further a mandatory submission for ANDAs with FDA and for NDAs with EU and Japan.
Investigational new drug application must be submitted after discovering a new drug and before beginning of clinical trials. Here given a brief note on the topic.The topics included are types of IND, criteria for application, Information in IND application, resources for IND application, laws.regulations, policies and procedures, IND forms and instructions, IND content requirements and review of IND
An Investigational New Drug Application (IND) is a request from a clinical study sponsor to obtain authorization from the Food and Drug Administration (FDA) to administer an investigational drug or biological product to humans
IND (Investigational New Drug) industrial perspectiveAYESHA NAZEER
Describing the Industry's/sponsor's/drug manufacturers' perspective of the Investigational New Drug Application (IND) program based on the survey conducted by the Office Of Inspector General (OIG).
INTRODUCTION
IND TYPES
IND CATEGORIES
THE IND APPLICATION MUST CONTAIN INFORMATION IN THREE BROAD AREA
THE REGULATORY ENVIRONMENT AND FDA ROLE
LIST OF IMPORTANT SECTIONS
GENERAL PRINCIPLES
INVESTIGATIONAL NEW DRUG GUIDANCE AND PLANNING
FDA FORM 1571
FDA FORM 1572
FDA FORM 3674
SUBMITTING AN IND
FOLLOWING RECEIPT OF IND BY THE FDA
RESPONDING TO A CLINICAL HOLD
REGULATORY REQUIREMENTS FOR AN IND DURING STUDY AND AT COMPLETION
PROTOCOL AMENDMENTS (21 CFR 312.30)
INFORMATION AMENDMENTS (21 CFR 312.31)
SAFETY REPORTS (21 CFR 312.32)
ANNUAL REPORTS (21 CFR 312.33)
WITHDRAWAL, TERMINATION, AND INACTIVATION
MONITORING RESPONSIBILITIES FOR SPONSOR-INVESTIGATORS
Memorandum Of Association Constitution of Company.pptseri bangash
www.seribangash.com
A Memorandum of Association (MOA) is a legal document that outlines the fundamental principles and objectives upon which a company operates. It serves as the company's charter or constitution and defines the scope of its activities. Here's a detailed note on the MOA:
Contents of Memorandum of Association:
Name Clause: This clause states the name of the company, which should end with words like "Limited" or "Ltd." for a public limited company and "Private Limited" or "Pvt. Ltd." for a private limited company.
https://seribangash.com/article-of-association-is-legal-doc-of-company/
Registered Office Clause: It specifies the location where the company's registered office is situated. This office is where all official communications and notices are sent.
Objective Clause: This clause delineates the main objectives for which the company is formed. It's important to define these objectives clearly, as the company cannot undertake activities beyond those mentioned in this clause.
www.seribangash.com
Liability Clause: It outlines the extent of liability of the company's members. In the case of companies limited by shares, the liability of members is limited to the amount unpaid on their shares. For companies limited by guarantee, members' liability is limited to the amount they undertake to contribute if the company is wound up.
https://seribangash.com/promotors-is-person-conceived-formation-company/
Capital Clause: This clause specifies the authorized capital of the company, i.e., the maximum amount of share capital the company is authorized to issue. It also mentions the division of this capital into shares and their respective nominal value.
Association Clause: It simply states that the subscribers wish to form a company and agree to become members of it, in accordance with the terms of the MOA.
Importance of Memorandum of Association:
Legal Requirement: The MOA is a legal requirement for the formation of a company. It must be filed with the Registrar of Companies during the incorporation process.
Constitutional Document: It serves as the company's constitutional document, defining its scope, powers, and limitations.
Protection of Members: It protects the interests of the company's members by clearly defining the objectives and limiting their liability.
External Communication: It provides clarity to external parties, such as investors, creditors, and regulatory authorities, regarding the company's objectives and powers.
https://seribangash.com/difference-public-and-private-company-law/
Binding Authority: The company and its members are bound by the provisions of the MOA. Any action taken beyond its scope may be considered ultra vires (beyond the powers) of the company and therefore void.
Amendment of MOA:
While the MOA lays down the company's fundamental principles, it is not entirely immutable. It can be amended, but only under specific circumstances and in compliance with legal procedures. Amendments typically require shareholder
Get Bad Credit Loans with Guaranteed ApprovalDollarLoan Hub
While no lender can truly guarantee approval for a loan, there are steps individuals with bad credit can take to improve their chances of securing a loan.
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
"𝑩𝑬𝑮𝑼𝑵 𝑾𝑰𝑻𝑯 𝑻𝑱 𝑰𝑺 𝑯𝑨𝑳𝑭 𝑫𝑶𝑵𝑬"
𝐓𝐉 𝐂𝐨𝐦𝐬 (𝐓𝐉 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬) is a professional event agency that includes experts in the event-organizing market in Vietnam, Korea, and ASEAN countries. We provide unlimited types of events from Music concerts, Fan meetings, and Culture festivals to Corporate events, Internal company events, Golf tournaments, MICE events, and Exhibitions.
𝐓𝐉 𝐂𝐨𝐦𝐬 provides unlimited package services including such as Event organizing, Event planning, Event production, Manpower, PR marketing, Design 2D/3D, VIP protocols, Interpreter agency, etc.
Sports events - Golf competitions/billiards competitions/company sports events: dynamic and challenging
⭐ 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐬:
➢ 2024 BAEKHYUN [Lonsdaleite] IN HO CHI MINH
➢ SUPER JUNIOR-L.S.S. THE SHOW : Th3ee Guys in HO CHI MINH
➢FreenBecky 1st Fan Meeting in Vietnam
➢CHILDREN ART EXHIBITION 2024: BEYOND BARRIERS
➢ WOW K-Music Festival 2023
➢ Winner [CROSS] Tour in HCM
➢ Super Show 9 in HCM with Super Junior
➢ HCMC - Gyeongsangbuk-do Culture and Tourism Festival
➢ Korean Vietnam Partnership - Fair with LG
➢ Korean President visits Samsung Electronics R&D Center
➢ Vietnam Food Expo with Lotte Wellfood
"𝐄𝐯𝐞𝐫𝐲 𝐞𝐯𝐞𝐧𝐭 𝐢𝐬 𝐚 𝐬𝐭𝐨𝐫𝐲, 𝐚 𝐬𝐩𝐞𝐜𝐢𝐚𝐥 𝐣𝐨𝐮𝐫𝐧𝐞𝐲. 𝐖𝐞 𝐚𝐥𝐰𝐚𝐲𝐬 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐭𝐡𝐚𝐭 𝐬𝐡𝐨𝐫𝐭𝐥𝐲 𝐲𝐨𝐮 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐚 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐨𝐮𝐫 𝐬𝐭𝐨𝐫𝐢𝐞𝐬."
Putting the SPARK into Virtual Training.pptxCynthia Clay
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
Accpac to QuickBooks Conversion Navigating the Transition with Online Account...PaulBryant58
This article provides a comprehensive guide on how to
effectively manage the convert Accpac to QuickBooks , with a particular focus on utilizing online accounting services to streamline the process.
As a business owner in Delaware, staying on top of your tax obligations is paramount, especially with the annual deadline for Delaware Franchise Tax looming on March 1. One such obligation is the annual Delaware Franchise Tax, which serves as a crucial requirement for maintaining your company’s legal standing within the state. While the prospect of handling tax matters may seem daunting, rest assured that the process can be straightforward with the right guidance. In this comprehensive guide, we’ll walk you through the steps of filing your Delaware Franchise Tax and provide insights to help you navigate the process effectively.
12 Conversion Rate Optimization Strategies for Ecommerce Websites.pdfSOFTTECHHUB
Did you know that the average ecommerce conversion rate is a mere 2.86%? That means for every 100 visitors to an online store, only about 3 make a purchase. With so much competition and an ever-increasing number of online shoppers, optimizing your website for higher conversions is crucial for the success of your ecommerce business.
In this comprehensive guide, we'll dive into 12 powerful conversion rate optimization (CRO) strategies that can help you turn more website visitors into paying customers. From improving website speed and optimizing for mobile devices to leveraging social proof and utilizing analytics, we'll cover actionable tips and best practices to help you maximize your ecommerce website's potential.
IPTV Subscription UK: Your Guide to Choosing the Best ServiceDragon Dream Bar
"IPTV Subscription UK" (Internet Protocol Television) has revolutionized the way people watch TV, offering a vast array of channels and on-demand content delivered over the internet. If you’re considering an IPTV subscription in the UK, here’s a comprehensive guide to help you choose the best service for your needs.
University of Connecticut Fees, Courses, Acceptance Rate, Admission deadline,...dvividconsultant15
Back in 1881, the University of Connecticut (UConn) came into existence as a private land-grant research institution, quickly earning a spot among the top academic players in the United States. UConn isn't just about academics—it's a key player in the economic and cultural landscape. In fact, as a founding member of the New England's Knowledge Corridor, a collaborative effort between Hartford and Springfield, the university is deeply involved in fostering regional development, economic growth, and cultural richness.
Business Valuation Principles for EntrepreneursBen Wann
This insightful presentation is designed to equip entrepreneurs with the essential knowledge and tools needed to accurately value their businesses. Understanding business valuation is crucial for making informed decisions, whether you're seeking investment, planning to sell, or simply want to gauge your company's worth.
Lars Winkelbauer — Sustainable Development in the Era of Air Cargo Technologylarswinkelbauer23
In the contemporary world, the air cargo industry plays a pivotal role in global trade and commerce. With technological advancements shaping the industry, there is a growing emphasis on sustainable development to minimize environmental impact. This article delves into the realm of air cargo technology and sustainable practices, shedding light on the initiatives and innovations driving the industry towards a greener future. Additionally, Lars Winkelbauer — Navigating the Ethical Landscape: AI in Sustainable Development — provides insightful perspectives on ensuring ethical considerations are integrated into the adoption of these technological advancements.
2. DRUG DEVELOPMENT
Development of a new
therapeutic drug is a complex,
lengthy and expensive process
costs nearly 900 million dollars
and an average of 15 years.
3. THE TWO TRANSLATIONALTHE TWO TRANSLATIONAL
BLOCKSBLOCKS
Basic
Biomedical
Research
Clinical
Science
and
Knowledge
Goal:
Improved
Health
Translation from
basic science to
human studies
Translation of
new knowledge
into clinical practice
6. IND (Investigational New Drug
Application)
FDA's role in the development of a new drug begins
when the drug's sponsor has screened the new
molecule for pharmacological activity and acute toxicity
potential in animals, wants to test its diagnostic or
therapeutic potential in humans
The molecule changes in legal status under the Federal
Food, Drug, and Cosmetic Act and becomes a new
drug subject to specific requirements of the drug
regulatory system
Drug is to be the subjected to an approved marketing
application before it is transported or distributed
across state lines
IND- notice of claimed investigational exemption for a
new drug must be filed with regulatory body
7. TYPES OF INDTYPES OF IND
Investigator IND
o Submitted by a physician who both initiates and conducts an
investigation, and under whose immediate direction the
investigational drug is administered or dispensed.
o Physician might submit a research IND to propose studying an
unapproved drug, or an approved product for a new indication or
in a new patient population
Emergency Use IND
o Allows FDA to authorize use of an experimental drug in an
emergency situation
o Does not allow time for submission of an IND in accordance with
21CFR , Sec. 312.23 or Sec. 312.34
Treatment IND
o Submitted for experimental drugs showing promise in clinical
testing for serious or immediately life-threatening conditions while
the final clinical work is conducted and the FDA review takes place
8. CLASSIFICATION OF INDCLASSIFICATION OF IND
Commercial
o Permits sponsor to collect data on clinical safety and
effectiveness needed for application for marketing in
the form of NDA
Research (non-commercial)
o Permits the sponsor to use drug in research to
obtain advanced scientific knowledge of new drug
o No plan to market the product
9. CONTENT OF INDCONTENT OF IND
In three broad areas:
Animal Pharmacology and Toxicology Studies –
o An assessment as to whether the product is reasonably safe for initial
testing in humans
o Any previous experience with the drug in humans
Manufacturing Information
o composition, manufacturer, stability, and controls used for manufacturing
the drug
Clinical Protocols and Investigator Information
o Commitments to obtain informed consent from the research subjects, to
obtain review of the study by an institutional review board (IRB), and to
adhere to the investigational new drug regulations.
Once the IND is submitted, the sponsor must wait 30 days30 days before
initiating any clinical trials. During this time, FDA has an opportunity
to review the IND for safety to assure that research subjects will not
be subjected to unreasonable risk
10. FORMAT OF INDFORMAT OF IND
A. Cover sheet (Form FDA-1571)
o Name, address, telephone of sponsor
o Identification of phases
o Commitment not to begin CT until IND approval
o Commitment by IRB- Form 56
o Commitment for conducting CT- accordance with regulations
o Name, title – Monitor
o Name, title – person(s) for reviewing
o Name, Address of CRO, if any
o Signature of sponsor
B. Table of contents
C. Introductory statement & general investigational plan
D. Investigators brochure
E. Study protocol
F. Investigator facilities & IRB data
G. Chemistry manufacturing & control data
H. Pharmacology & toxicology data
I. Previous human experience
11. RESOURCES FOR INDRESOURCES FOR IND
APPLICATIONSAPPLICATIONS
• Pre-Investigational New Drug Application (IND) Consultation Pr
o Offered by CDER (Center for Drug Evaluation and Research) to
foster early communications between sponsors and new
drug review divisions in order to provide guidance on the
data necessary to warrant IND submission.
• Guidance Documents for INDs
o documents are prepared for FDA review staff and
applicants/sponsors to provide guidelines to the
processing, content, and evaluation/approval of
applications and also to the design, production,
manufacturing, and testing of regulated products
12. GUIDANCE DOCUMENTSGUIDANCE DOCUMENTS
For the complete list of CDER guidance, please see theFor the complete list of CDER guidance, please see the
Guidance IndexGuidance Index
Safety Reporting Requirements for INDs and BE/BA Studies
CGMP for Phase 1 Investigational Drugs
Exploratory IND Studies
Content and Format of Investigational New Drug Applications (INDs) for Phase 1
Studies of Drugs, Including Well Characterized, Therapeutic, Biotechnology-Derived
Products
Q & A - Content and Format of INDs for Phase 1 Studies of Drugs, Including Well-
Characterized, Therapeutic, Biotechnology-Derived Products
Bioavailability and Bioequivalence Studies for Orally Administered Drug Products
IND Exemptions for Studies of Lawfully Marketed Drug or Biological Products for
the Treatment of Cancer
Guideline for Drug Master Files
A Drug Master File (DMF) is a submission to the Food and Drug Administration (FDA)
that may be used to provide confidential detailed information about facilities,
processes, or articles used in the manufacturing, processing, packaging, and storing
of one or more human drugs.
Required Specifications for FDA's IND, NDA, and ANDA Drug Master File Binders
Immunotoxicology Evaluation of Investigational New Drugs
13. LAWS,REGULATIONS, POLICIES,LAWS,REGULATIONS, POLICIES,
PROCEDURESPROCEDURES
The Federal Food, Drug, and Cosmetic Act is the basic
food and drug law of the U.S The law is intended
to assure consumers that foods are pure and
wholesome, safe to eat, and produced under
sanitary conditions; that drugs and devices are safe
and effective for their intended uses; that cosmetics
are safe and made from appropriate ingredients;
and that all labeling and packaging is truthful,
informative, and not deceptive.
14. LAWS,REGULATIONS, POLICIES,LAWS,REGULATIONS, POLICIES,
PROCEDURES Cont…..PROCEDURES Cont…..
Code Of Federal Regulations (CFR)
o The final regulations published in the Federal Register (daily published record of
proposed rules, final rules, meeting notices, etc.) are collected in the CFR.
o The CFR is divided into 50 titles that represent broad areas subject to Federal
regulations.
o The FDA's portion of the CFR interprets the The Federal Food, Drug, and Cosmetic
Act and related statutes. Section 21 of the CFR contains most regulations
pertaining to food and drugs.
21CFR Part 312 Investigational New Drug Application
21CFR Part 314
INDA and NDA Applications for FDA Approval to
Market a New Drug (New Drug Approval)
21CFR Part 316 Orphan Drugs
21CFR Part 58 Good Lab Practice for Nonclinical Laboratory
[Animal] Studies
21CFR Part 50 Protection of Human Subjects
21CFR Part 56 Institutional Review Boards
21CFR Part 201 Drug Labeling
21CFR Part 54 Financial Disclosure by Clinical Investigators
15. LAWS,REGULATIONS, POLICIES,LAWS,REGULATIONS, POLICIES,
PROCEDURES Cont…..PROCEDURES Cont…..
CDER's Manual of Policies and
Procedures (MaPPs)
MaPPS are approved instructions for
internal practices and procedures
followed by CDER staff to help
standardize the new drug review process
and other activities.
17. Guidance for preparation of INDGuidance for preparation of IND
Reference to document:
http://www.fda.gov/cder/regulatory/applicat
ions/ind_page_1.htm
19. NDANDA (New Drug Application)(New Drug Application)
The vehicle through which drug sponsors
formally propose that the regulatory body
approve a new pharmaceutical for sale and
marketing.
Form 44
The data gathered during the animal studies and
human clinical trials of an Investigational new
product become part of the NDA.
20. GOAL OF NDAGOAL OF NDA
Provide enough information to permit FDA reviewers to
establish the following:
Safety & effectiveness of drug?
Benefits overweigh risks?
Is the drug’s proposed labelling (package insert)
appropriate, and what should it contain?
Are the methods used in manufacturing (Good
Manufacturing Practice, GMP) the drug and the controls
used to maintain the drug’s quality adequate to preserve
the drug’s identity, strength, quality, and purity?
Risk Benefit
21. NDA CONTENTSNDA CONTENTS
1. Introduction
o Brief description of the drug and the therapeutic class to which it
belongs
2. Chemical and
pharmaceutical information
3. Animal Pharmacology
4. Animal Toxicology
5. Human/Clinical Pharmacology phase I
6. Therapeutic exploratory trials (Phase II)
7. Therapeutic confirmatory trials (Phase III)
8. Special Studies
o Geriatrics, pediatrics, pregnant or nursing women
9. Regulatory status in other countries
10. Prescribing information
11. Samples and Testing Protocol/s
22. Once the application is submitted, the FDA has 60 days
to conduct a preliminary review which will assess
whether the NDA is "sufficiently complete to permit asufficiently complete to permit a
substantive review”substantive review”
If everything is found to be acceptable, the FDA will
decide if the NDA will get a standard or accelerated
review and communicate the acceptance of the
application and their review choice in another
communication known as the 74-day letter74-day letter
A standard review implies an FDA decision within about
10 months10 months
23. CONTENTS OF ANDACONTENTS OF ANDA
Data for a drug already approved in the countryData for a drug already approved in the country
1. Introduction
2. Chemical and pharmaceutical information
3. Marketing information
4. Special studies conducted with approval of
Licensing Authority
24. REQUIREMENTS FOR SIMILARREQUIREMENTS FOR SIMILAR
PRODUCTSPRODUCTS
GENERIC DRUGS
Drug product that is comparable to any innovator drug
product in dosage form, strength, route of
administration, quality, performance characteristics and
intended use but is produced & distributed without
patent application.
This drug have already been approved via an NDA
submitted by another maker are approved via an
Abbreviated New Drug Application (ANDA), which does
not require all of the clinical trials normally required for a
new drug in an NDA
o No need for preclinical and clinical data
o Bioequivalence
25. REQUIREMENTS FOR SIMILARREQUIREMENTS FOR SIMILAR
PRODUCTS Cont….PRODUCTS Cont….
BIOLOGICS
Biologics such as vaccines and many recombinant
proteins used in medical treatments are generally
approved by FDA via a Biologic License Application
(BLA), rather than an NDA.
Manufacture of biologics is considered to differ
fundamentally from that of less complex chemicals,
requiring a somewhat different approval process.
26. REQUIREMENTS FOR SIMILARREQUIREMENTS FOR SIMILAR
PRODUCTS Cont….PRODUCTS Cont….
MEDICAL DEVICES
Medical devices are approved by a variety of methods depending
on the class of the device
Class I: Devices that do not require premarket approval
Eg; Dental flossEg; Dental floss
A Pre-market Application (PMA) largely equivalent to an NDA is
required for class III devices.These tend to be devices that are
permanently implanted into a human body or may be necessary
to sustain life.
Eg; artificial heartEg; artificial heart
510(k) approval that shows the device is equal to or better than
a predicate device already on the market is required for class II
devices.
Eg;Eg;Diagnostic tests, cardiac catheters, and amalgam alloysDiagnostic tests, cardiac catheters, and amalgam alloys
used to fill cavities, hearing aidsused to fill cavities, hearing aids
27. REQUIREMENTS FOR SIMILARREQUIREMENTS FOR SIMILAR
PRODUCTS Cont….PRODUCTS Cont….
Drugs for life threatening/serious
disease/relevance to India
Clinical and toxicological data may be
abbreviated, deferred or omitted as per the
licensing authority